Diosgenin 3-[glucosyl-(1->4)-rhamnosyl-(1->4)-glucoside] (C45H72O17)

Structural Information

Molecular Formula

SMILES

CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)OC9C(C(C(C(O9)CO)O)O)O)O)O)O)O)C)C)C)OC1

InChI

InChI=1S/C45H72O17/c1-19-8-13-45(55-18-19)20(2)30-27(62-45)15-26-24-7-6-22-14-23(9-11-43(22,4)25(24)10-12-44(26,30)5)57-41-37(54)34(51)39(29(17-47)59-41)61-40-36(53)33(50)38(21(3)56-40)60-42-35(52)32(49)31(48)28(16-46)58-42/h6,19-21,23-42,46-54H,7-18H2,1-5H3

InChIKey

YIINVROKKFPIQD-UHFFFAOYSA-N

Compound name

2-[6-[4,5-dihydroxy-2-(hydroxymethyl)-6-(5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-2-methyloxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Related CIDs

2D Structure

Predicted Collision Cross Section

m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Å²) per adduct calculated using CCSbase.
Adduct	m/z	Predicted CCS (Å²)
[M+H]+	885.484176	295.3
[M+Na]+	907.466118	295.4
[M-H]-	883.469624	290.1
[M+NH4]+	902.510723	295.6
[M+K]+	923.440058	301.5
[M+H-H2O]+	867.474160	293.4
[M+HCOO]-	929.475101	296.2
[M+CH3COO]-	943.490751	298.7
[M+Na-2H]-	905.451566	314.7
[M]+	884.47635142	297.3
[M]-	884.47744858	297.3

Adduct

m/z

Predicted CCS (Å²)

[M+H]+

885.484176

295.3

[M+Na]+

907.466118

295.4

[M-H]-

883.469624

290.1

[M+NH4]+

902.510723

295.6

[M+K]+

923.440058

301.5

[M+H-H2O]+

867.474160

293.4

[M+HCOO]-

929.475101

296.2

[M+CH3COO]-

943.490751

298.7

[M+Na-2H]-

905.451566

314.7

[M]+

884.47635142

297.3

[M]-

884.47744858

297.3

m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Å²) per adduct calculated using CCSbase.

Diosgenin 3-[glucosyl-(1->4)-rhamnosyl-(1->4)-glucoside]

Structural Information

2D Structure

Profile

Predicted Collision Cross Section

Literature stripe

Patent stripe